| Ausstehende Aktien | 106,464,482 shares |
| Insider-Aktien | 34.833.475 shares |
| Insider-Besitz | 32,72 % |
| Insider gesamt | 32 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
9947 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Cypherpunk Technologies Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Jason Baum Chief Scientific Officer - [O] | 15.896 | 15.896 | |
|
BeiGene, Ltd.
10% Owner -
|
7.348.437 | 734.844 | |
| Monica Bertagnolli | 55.000 | ||
| James H Cavanaugh Director - [D] | 168.963 | 168.963 | |
| Thomas John Dietz Director - [D] | 152.500 | 152.500 | |
|
Joseph Edelman
10% Owner -
|
3.508.771 | 847.650 | |
|
Gilead Sciences Inc
10% Owner -
|
5.319.148 | 5.319.148 | |
| Christine Granfield VP, Head of Reg Affairs/Qual - [O] | 15.896 | 15.896 | |
|
HealthCare Partners VIII, L.P.
10% Owner -
|
0 | 0 | |
|
HealthCare Partners VIII, LLC
10% Owner -
|
0 | 0 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
HealthCare Ventures IX, L.P.
10% Owner -
|
4.144.804 | 414.480 | |
|
HealthCare Ventures VIII, L.P.
10% Owner -
|
0 | 0 | |
|
Healthcare Partners IX, LLC
10% Owner -
|
4.144.804 | 414.480 | |
| Augustine Lawlor Chief Operating Officer - [O] | 19.789 | 19.789 | |
| William Li Director - [D] | 168.750 | 168.750 | |
|
Eli & Co Lilly
10% Owner -
|
2.958.614 | 295.861 | |
|
John W Littlechild
Director, 10% Owner -
[D]
|
5.236.812 | 523.681 | |
| Joseph Loscalzo Director - [D] | 168.750 | 168.750 | |
| Martin Patricia A. Director - [D] | 168.750 | 168.750 | |
| Nissim Mashiach Director - [D] | 168.750 | 168.750 | |
|
William Patrick III McEvoy
Chief Investment Officer, Director, 10% Owner -
[D]
[O]
|
8.283.761 | 8.283.761 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Christopher Mirabelli Director - [D] | 130.376 | 130.376 | |
| John Mark O'Mahony Chief Manufacturing Officer - [O] | 27.500 | 27.500 | |
| Douglas E Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director - [D] [O] | 106.858 | 106.858 | |
| Khing Djien Oei Director - [D] | 168.750 | 168.750 | |
|
Perceptive Advisors Llc
10% Owner -
|
8.476.496 | 847.650 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
3.508.771 | 847.650 | |
| Christian M Richard Director - [D] | 168.750 | 168.750 | |
| Richard Schilsky Director - [D] | 168.750 | 168.750 | |
| Cynthia Sirard Chief Medical Officer - [O] | 27.500 | 27.500 | |
|
Harold R Werner
10% Owner -
|
2.137 | 523.681 | |
|
Winklevoss Capital Fund, LLC
10% Owner -
|
16.567.522 | 16.567.522 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in CYPH / Cypherpunk Technologies Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in CYPH / Cypherpunk Technologies Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | 4 | Mirabelli Christopher | CYPH | Common Stock | D | 0,7105 | -60.000 | -43 | 130.376 | ||||
| 2026-03-17 | 2026-03-13 | 4 | Dietz Thomas John | CYPH | Common Stock | D | 104.500 | 152.500 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Mirabelli Christopher | CYPH | Common Stock | D | 94.050 | 190.376 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Mirabelli Christopher | CYPH | Common Stock | D | 74.700 | 96.326 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | LI WILLIAM | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | LI WILLIAM | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Oei Khing Djien | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Oei Khing Djien | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Richard Christian M | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Richard Christian M | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Mashiach Nissim | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Mashiach Nissim | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Schilsky Richard | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Schilsky Richard | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Martin Patricia A. | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | Martin Patricia A. | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | LOSCALZO JOSEPH | CYPH | Common Stock | D | 94.050 | 168.750 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | LOSCALZO JOSEPH | CYPH | Common Stock | D | 74.700 | 74.700 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | CAVANAUGH JAMES H | CYPH | Common Stock | D | 94.050 | 168.963 | ||||||
| 2026-03-17 | 2026-03-13 | 4 | CAVANAUGH JAMES H | CYPH | Common Stock | D | 74.700 | 74.913 | ||||||
| 2025-12-30 | 2025-12-26 | 4 | Dietz Thomas John | CYPH | Common Stock | D | 1,2000 | -35.000 | -42 | 48.000 | ||||
| 2025-12-30 | 2025-12-26 | 4 | Dietz Thomas John | CYPH | Common Stock | D | 83.000 | 83.000 | ||||||
| 2025-12-30 | 2025-12-23 | 4 | Mirabelli Christopher | CYPH | Common Stock | D | 712 | 21.626 | ||||||
| 2025-12-30 | 2025-12-23 | 4 | Mirabelli Christopher See footnotes | CYPH | Common Stock | I | -2.136 | 0 | ||||||
| 2025-12-30 | 2025-12-23 | 4 | ONSI DOUGLAS E | CYPH | Common Stock | D | 712 | 106.858 | ||||||
| 2025-12-30 | 2025-12-23 | 4 | ONSI DOUGLAS E See footnotes | CYPH | Common Stock | I | -2.136 | 0 | ||||||
| 2025-11-21 | 3 | Winklevoss Capital Fund, LLC By Winklevoss Treasury Investments, LLC | CYPH | Common Stock | I | 8.283.761 | ||||||||
| 2025-11-20 | 3 | McEvoy William Patrick III See Notes | CYPH | Common Shares | I | 8.283.761 | ||||||||
| 2025-11-19 | 2025-11-17 | 4 | Mirabelli Christopher See footnotes | CYPH | Common Stock | I | 3,1400 | -414.479 | -1.301 | 2.136 | ||||
| 2025-11-19 | 2025-11-17 | 4 | Mirabelli Christopher See footnotes | CYPH | Common Stock | I | 3,1400 | -261.840 | -822 | 416.616 | ||||
| 2025-11-19 | 2025-11-17 | 4 | ONSI DOUGLAS E See footnotes | CYPH | Common Stock | I | 3,1400 | -414.479 | -1.301 | 2.136 | ||||
| 2025-11-19 | 2025-11-17 | 4 | ONSI DOUGLAS E See footnotes | CYPH | Common Stock | I | 3,1400 | -261.840 | -822 | 416.616 | ||||
| 2025-11-19 | 2025-11-17 | 4 | CAVANAUGH JAMES H See footnotes | CYPH | Common Stock | I | 3,1400 | -261.840 | -822 | 0 | ||||
| 2025-04-01 | 2025-03-28 | 4 | ONSI DOUGLAS E | LPTX | Common Stock | D | 32.500 | 106.146 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | Granfield Christine | LPTX | Common Stock | D | 0,3166 | -6.604 | -2 | 15.896 | ||||
| 2025-04-01 | 2025-03-28 | 4 | Granfield Christine | LPTX | Common Stock | D | 22.500 | 22.500 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | LAWLOR AUGUSTINE | LPTX | Common Stock | D | 0,3166 | -7.797 | -2 | 19.789 | ||||
| 2025-04-01 | 2025-03-28 | 4 | LAWLOR AUGUSTINE | LPTX | Common Stock | D | 22.500 | 27.586 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | Baum Jason | LPTX | Common Stock | D | 0,3166 | -6.604 | -2 | 15.896 | ||||
| 2025-04-01 | 2025-03-28 | 4 | Baum Jason | LPTX | Common Stock | D | 22.500 | 22.500 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | O'Mahony John Mark | LPTX | Common Stock | D | 22.500 | 27.500 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | Sirard Cynthia | LPTX | Common Stock | D | 22.500 | 27.500 | ||||||
| 2025-04-01 | 2025-03-28 | 4 | Mirabelli Christopher | LPTX | Common Stock | D | 0,3166 | -6.672 | -2 | 20.914 | ||||
| 2025-04-01 | 2025-03-28 | 4 | Mirabelli Christopher | LPTX | Common Stock | D | 22.500 | 27.586 | ||||||
| 2024-11-15 | 2024-11-13 | 4 | CAVANAUGH JAMES H | LPTX | Common Stock | D | 2,8200 | 213 | 1 | 213 | ||||
| 2024-11-15 | 2024-11-13 | 4 | LAWLOR AUGUSTINE See Footnotes | LPTX | Common Stock | I | 2,8200 | 2.136 | 6 | 678.456 | ||||
| 2024-11-15 | 2024-11-13 | 4 | ONSI DOUGLAS E See footnotes | LPTX | Common Stock | I | 2,8200 | 2.136 | 6 | 678.456 | ||||
| 2024-11-15 | 2024-11-13 | 4 | Mirabelli Christopher See Footnotes | LPTX | Common Stock | I | 2,8200 | 2.136 | 6 | 678.456 | ||||
| 2024-04-19 | 3 | GILEAD SCIENCES INC | LPTX | Common Stock | D | 5.319.148 | ||||||||
| 2024-01-30 | 2024-01-26 | 4 | Mirabelli Christopher | LPTX | Common Stock | D | 5.000 | 5.086 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | O'Mahony John Mark | LPTX | Common Stock | D | 5.000 | 5.000 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Sirard Cynthia | LPTX | Common Stock | D | 5.000 | 5.000 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | LAWLOR AUGUSTINE | LPTX | Common Stock | D | 5.000 | 5.086 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | ONSI DOUGLAS E | LPTX | Common Stock | D | 7.500 | 73.646 | ||||||
| 2023-03-21 | 2023-03-17 | 4 | ONSI DOUGLAS E | LPTX | Common Stock | D | 660.606 | 661.466 | ||||||
| 2022-02-03 | 2022-01-31 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 1,94 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Sirard Cynthia | LPTX | Restricted Stock Units | D | 0,00 | 225.000 | 225.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 1,94 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | O'Mahony John Mark | LPTX | Restricted Stock Units | D | 0,00 | 225.000 | 225.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | LAWLOR AUGUSTINE | LPTX | Restricted Stock Units | D | 0,00 | 225.000 | 225.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 1,94 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 1,94 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 1,94 | 60.000 | 60.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Mirabelli Christopher | LPTX | Restricted Stock Units | D | 0,00 | 225.000 | 225.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | ONSI DOUGLAS E | LPTX | Restricted Stock Units | D | 0,00 | 325.000 | 325.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Bertagnolli Monica | LPTX | Stock Option (Right to Buy) | D | 1,94 | 55.000 | 55.000 | |||||
| 2022-02-02 | 2022-01-31 | 4 | Granfield Christine | LPTX | Restricted Stock Units | D | 0,00 | 225.000 | 225.000 | |||||
| 2021-09-28 | 2021-09-24 | 4 | PERCEPTIVE ADVISORS LLC | LPTX | Warrants (right to buy) | I | 0,00 | 2,8490 | 3.508.771 | 9.996 | 3.508.771 | |||
| 2021-09-28 | 2021-09-24 | 4 | BeiGene, Ltd. | LPTX | Common Stock | D | 2,8500 | 2.543.800 | 7.250 | 7.348.437 | ||||
| 2021-09-10 | 2021-09-08 | 4 | Bertagnolli Monica | LPTX | Stock Option (Right to Buy) | D | 1,58 | 16.150 | 16.150 | |||||
| 2021-09-10 | 2021-09-08 | 4 | Bertagnolli Monica | LPTX | Stock Option (Right to Buy) | D | 1,58 | 65.000 | 65.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Granfield Christine | LPTX | Employee Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Sirard Cynthia | LPTX | Employee Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | O'Mahony John Mark | LPTX | Employee Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | LAWLOR AUGUSTINE | LPTX | Employee Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Mirabelli Christopher | LPTX | Stock Option (Right to Buy) | D | 1,62 | 30.000 | 30.000 | |||||
| 2021-02-12 | 2021-02-09 | 4 | LAWLOR AUGUSTINE | LPTX | Warrant (Right to Buy) | I | 1,95 | 11.544 | 11.544 | |||||
| 2021-02-12 | 2021-02-09 | 4 | LAWLOR AUGUSTINE | LPTX | Warrant (Right to Buy) | I | 1,95 | -571.428 | 0 | |||||
| 2021-02-11 | 2021-02-09 | 4 | HealthCare Ventures IX, L.P. | LPTX | Warrant (Right to Buy) | D | 1,95 | -571.428 | 0 | |||||
| 2021-02-11 | 2021-02-09 | 4 | ONSI DOUGLAS E | LPTX | Warrant (Right to Buy) | I | 1,95 | 11.544 | 11.544 | |||||
| 2021-02-11 | 2021-02-09 | 4 | ONSI DOUGLAS E | LPTX | Warrant (Right to Buy) | D | 1,95 | -571.428 | 0 | |||||
| 2021-02-11 | 2021-02-09 | 4 | CAVANAUGH JAMES H | LPTX | Warrant (Right to Buy) | I | 1,95 | 1.154 | 1.154 | |||||
| 2021-02-11 | 2021-02-09 | 4 | Mirabelli Christopher | LPTX | Warrant (Right to Buy) | I | 1,95 | 11.544 | 11.544 | |||||
| 2021-02-11 | 2021-02-09 | 4 | Mirabelli Christopher | LPTX | Warrant (Right to Buy) | D | 1,95 | -571.428 | 0 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Mirabelli Christopher | LPTX | Restricted Stock Units | D | 0,00 | 50.000 | 50.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Mirabelli Christopher | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 150.000 | 150.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Granfield Christine | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 50.000 | 50.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Sirard Cynthia | LPTX | Restricted Stock Units | D | 0,00 | 50.000 | 50.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | Sirard Cynthia | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 150.000 | 150.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | O'Mahony John Mark | LPTX | Restricted Stock Units | D | 0,00 | 50.000 | 50.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | O'Mahony John Mark | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 150.000 | 150.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | ONSI DOUGLAS E | LPTX | Restricted Stock Units | D | 0,00 | 75.000 | 75.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 175.000 | 175.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | LAWLOR AUGUSTINE | LPTX | Restricted Stock Units | D | 0,00 | 50.000 | 50.000 | |||||
| 2021-01-28 | 2021-01-26 | 4 | LAWLOR AUGUSTINE | LPTX | Employee Stock Option (Right to Buy) | D | 2,57 | 150.000 | 150.000 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 2,18 | 32.300 | 32.300 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 2,18 | 37.300 | 37.300 | |||||
| 2021-01-06 | 2021-01-04 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 2,18 | 32.300 | 32.300 | |||||
| 2021-01-06 | 2021-01-04 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 2,18 | 32.300 | 32.300 | |||||
| 2021-01-06 | 2021-01-04 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 2,18 | 32.300 | 32.300 | |||||
| 2020-12-30 | 2020-12-28 | 4 | HealthCare Ventures VIII, L.P. | LPTX | Common Stock | D | -2.618.406 | 0 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | LAWLOR AUGUSTINE | LPTX | Stock Option (Right to Buy) | D | 1,97 | 75.000 | 75.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Sirard Cynthia | LPTX | Stock Option (Right to Buy) | D | 1,97 | 75.000 | 75.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 1,97 | 75.000 | 75.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 1,97 | 10.000 | 10.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Mirabelli Christopher | LPTX | Stock Option (Right to Buy) | D | 1,97 | 75.000 | 75.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | O'Mahony John Mark | LPTX | Stock Option (Right to Buy) | D | 1,97 | 75.000 | 75.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 1,97 | 12.500 | 12.500 | |||||
| 2020-08-12 | 2020-08-10 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 1,97 | 10.000 | 10.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 1,97 | 10.000 | 10.000 | |||||
| 2020-08-12 | 2020-08-10 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 1,97 | 10.000 | 10.000 | |||||
| 2020-06-24 | 2020-06-22 | 4 | PERCEPTIVE ADVISORS LLC | LPTX | Common Stock | I | 2,0000 | 1.750.000 | 3.500 | 8.476.496 | ||||
| 2020-04-20 | 3 | EDELMAN JOSEPH | LPTX | Common Stock | I | 13.452.992 | ||||||||
| 2020-04-20 | 3 | EDELMAN JOSEPH | LPTX | Common Stock | I | 13.452.992 | ||||||||
| 2020-04-20 | 3 | EDELMAN JOSEPH | LPTX | Common Stock | I | 13.452.992 | ||||||||
| 2020-04-20 | 3 | EDELMAN JOSEPH | LPTX | Common Stock | I | 13.452.992 | ||||||||
| 2020-04-20 | 3 | EDELMAN JOSEPH | LPTX | Common Stock | I | 13.452.992 | ||||||||
| 2020-04-13 | 2020-04-09 | 4 | LAWLOR AUGUSTINE | LPTX | Stock Option (Right to Buy) | D | 1,69 | 50.000 | 50.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | Mirabelli Christopher | LPTX | Stock Option (Right to Buy) | D | 1,69 | 50.000 | 50.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 1,69 | 10.000 | 10.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 1,69 | 10.000 | 10.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 1,69 | 10.000 | 10.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 1,69 | 10.000 | 10.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 1,69 | 12.500 | 12.500 | |||||
| 2020-04-13 | 2020-04-09 | 4 | O'Mahony John Mark | LPTX | Stock Option (Right to Buy) | D | 1,69 | 50.000 | 50.000 | |||||
| 2020-04-13 | 2020-04-09 | 4 | Sirard Cynthia | LPTX | Stock Option (Right to Buy) | D | 1,69 | 50.000 | 50.000 | |||||
| 2020-03-23 | 3 | BeiGene, Ltd. | LPTX | Common Stock | D | 9.609.274 | ||||||||
| 2020-03-23 | 3 | BeiGene, Ltd. | LPTX | Common Stock | D | 9.609.274 | ||||||||
| 2020-03-23 | 3 | BeiGene, Ltd. | LPTX | Common Stock | D | 9.609.274 | ||||||||
| 2020-03-19 | 2020-03-17 | 4 | ONSI DOUGLAS E | LPTX | Restricted Stock Units | D | 0,00 | 660.606 | 660.606 | |||||
| 2020-03-19 | 2020-03-17 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 1,42 | 500.000 | 500.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 2,94 | 20.000 | 20.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 2,94 | 25.000 | 25.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 2,94 | 20.000 | 20.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 2,94 | 20.000 | 20.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 2,94 | 20.000 | 20.000 | |||||
| 2020-03-04 | 2020-03-02 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 2,94 | 20.000 | 20.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 1,39 | 10.000 | 10.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Mirabelli Christopher | LPTX | Employee Stock Option (Right to Buy) | D | 1,39 | 200.000 | 200.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 1,39 | 15.000 | 15.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 1,39 | 10.000 | 10.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 1,39 | 10.000 | 10.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 1,39 | 200.000 | 200.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 1,39 | 10.000 | 10.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | LAWLOR AUGUSTINE | LPTX | Employee Stock Option (Right to Buy) | D | 1,39 | 200.000 | 200.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 1,39 | 10.000 | 10.000 | |||||
| 2019-02-05 | 2019-02-05 | 4 | HealthCare Ventures IX, L.P. | LPTX | Warrant (Right to Buy) | D | 1,95 | 571.428 | 571.428 | |||||
| 2019-02-05 | 2019-02-05 | 4 | HealthCare Ventures IX, L.P. | LPTX | Common Stock | D | 1,7500 | 571.428 | 1.000 | 4.144.804 | ||||
| 2019-02-05 | 2019-02-05 | 4 | ONSI DOUGLAS E | LPTX | Warrant (Right to Buy) | I | 1,95 | 571.428 | 592.797 | |||||
| 2019-02-05 | 2019-02-05 | 4 | ONSI DOUGLAS E | LPTX | Common Stock | I | 1,7500 | 571.428 | 1.000 | 4.114.804 | ||||
| 2019-02-05 | 2019-02-05 | 4 | LAWLOR AUGUSTINE | LPTX | Warrant (Right to Buy) | I | 1,95 | 571.428 | 592.797 | |||||
| 2019-02-05 | 2019-02-05 | 4 | LAWLOR AUGUSTINE | LPTX | Common Stock | I | 1,7500 | 571.428 | 1.000 | 4.114.804 | ||||
| 2019-02-05 | 2019-02-05 | 4 | Mirabelli Christopher | LPTX | Warrant (Right to Buy) | I | 1,75 | 571.428 | 592.797 | |||||
| 2019-02-05 | 2019-02-05 | 4 | Mirabelli Christopher | LPTX | Common Stock | I | 1,7500 | 571.428 | 1.000 | 4.114.804 | ||||
| 2019-01-03 | 2019-01-01 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 2,00 | 7.500 | 7.500 | |||||
| 2019-01-03 | 2019-01-01 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 2,00 | 7.500 | 7.500 | |||||
| 2019-01-03 | 2019-01-01 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 2,00 | 7.500 | 7.500 | |||||
| 2019-01-03 | 2019-01-01 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 2,00 | 9.375 | 9.375 | |||||
| 2019-01-03 | 2019-01-01 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 2,00 | 7.500 | 7.500 | |||||
| 2019-01-03 | 2019-01-01 | 4 | LAWLOR AUGUSTINE | LPTX | Employee Stock Option (Right to Buy) | D | 2,00 | 50.000 | 50.000 | |||||
| 2019-01-03 | 2019-01-01 | 4 | ONSI DOUGLAS E | LPTX | Employee Stock Option (Right to Buy) | D | 2,00 | 50.000 | 50.000 | |||||
| 2019-01-03 | 2019-01-01 | 4 | Mirabelli Christopher | LPTX | Employee Stock Option (Right to Buy) | D | 2,00 | 50.000 | 50.000 | |||||
| 2019-01-03 | 2019-01-01 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 2,00 | 7.500 | 7.500 | |||||
| 2018-08-13 | 2018-07-30 | 4 | LILLY ELI & CO | LPTX | Warrant (right to buy) | D | 6,08 | 331.221 | 331.221 | |||||
| 2018-08-01 | 2018-07-30 | 4 | WERNER HAROLD R | LPTX | Warrant (Right to Buy) | I | 6,08 | 2.137 | 2.137 | |||||
| 2018-08-01 | 2018-07-30 | 4 | CAVANAUGH JAMES H | LPTX | Warrant (Right to Buy) | D | 6,08 | 2.137 | 2.137 | |||||
| 2018-08-01 | 2018-07-30 | 4 | LITTLECHILD JOHN W | LPTX | Warrant (Right to Buy) | D | 6,08 | 2.137 | 2.137 | |||||
| 2018-08-01 | 2018-07-30 | 4 | LAWLOR AUGUSTINE See Footnotes | LPTX | Warrant (Right to Buy) | I | 6,08 | 21.369 | 21.369 | |||||
| 2018-08-01 | 2018-07-30 | 4 | Mirabelli Christopher See Footnotes | LPTX | Warrant (Right to Buy) | I | 6,08 | 21.369 | 21.369 | |||||
| 2018-08-01 | 2018-07-30 | 4 | ONSI DOUGLAS E | LPTX | Warrant (Right to Buy) | I | 6,08 | 21.369 | 21.369 | |||||
| 2018-08-01 | 2018-07-30 | 4 | HealthCare Ventures IX, L.P. | LPTX | Warrant (Right to Buy) | D | 6,08 | -1.057.769 | 0 | |||||
| 2018-04-20 | 2018-04-18 | 4 | ONSI DOUGLAS E | LPTX | Stock Option (Right to Buy) | D | 7,66 | 50.000 | 50.000 | |||||
| 2018-04-20 | 2018-04-18 | 4 | LAWLOR AUGUSTINE | LPTX | Stock Option (Right to Buy) | D | 7,66 | 50.000 | 50.000 | |||||
| 2018-04-20 | 2018-04-18 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2018-04-20 | 2018-04-18 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2018-04-20 | 2018-04-18 | 4 | Mirabelli Christopher | LPTX | Stock Option (Right to Buy) | D | 7,66 | 50.000 | 50.000 | |||||
| 2018-04-20 | 2018-04-18 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2018-04-20 | 2018-04-18 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2018-04-20 | 2018-04-18 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2018-04-20 | 2018-04-18 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 7,66 | 11.250 | 11.250 | |||||
| 2017-11-16 | 3/A | Healthcare Partners IX, LLC | LPTX | Common Stock | D | 2.515.607 | ||||||||
| 2017-11-16 | 3 | LILLY ELI & CO | LPTX | Common Stock | D | 2.958.614 | ||||||||
| 2017-11-16 | 3 | LILLY ELI & CO | LPTX | Common Stock | D | 2.958.614 | ||||||||
| 2017-11-16 | 2017-11-14 | 4 | LAWLOR AUGUSTINE | LPTX | Warrant (Right to Buy) | I | 6,08 | 1.057.769 | 1.057.769 | |||||
| 2017-11-16 | 2017-11-14 | 4 | LAWLOR AUGUSTINE | LPTX | Common Stock | I | 6,0850 | 1.057.769 | 6.437 | 3.573.376 | ||||
| 2017-11-16 | 2017-11-14 | 4 | Mirabelli Christopher | LPTX | Warrant (Right to Buy) | I | 6,08 | 1.057.769 | 1.057.769 | |||||
| 2017-11-16 | 2017-11-14 | 4 | Mirabelli Christopher | LPTX | Common Stock | I | 6,0850 | 1.057.769 | 6.437 | 3.573.376 | ||||
| 2017-11-16 | 2017-11-14 | 4 | HealthCare Ventures IX, L.P. | LPTX | Warrant (Right to Buy) | D | 6,08 | 1.057.769 | 1.057.769 | |||||
| 2017-11-16 | 2017-11-14 | 4 | HealthCare Ventures IX, L.P. | LPTX | Common Stock | D | 6,0850 | 1.057.769 | 6.437 | 3.573.376 | ||||
| 2017-11-16 | 2017-11-14 | 4 | ONSI DOUGLAS E | LPTX | Warrant (Right to Buy) | I | 6,08 | 1.057.769 | 1.057.769 | |||||
| 2017-11-16 | 2017-11-14 | 4 | ONSI DOUGLAS E | LPTX | Common Stock | I | 6,0850 | 1.057.769 | 6.437 | 3.573.376 | ||||
| 2017-02-24 | 3 | Healthcare Partners IX, LLC | LPTX | Common Stock | D | 5.031.214 | ||||||||
| 2017-02-24 | 3 | Healthcare Partners IX, LLC | LPTX | Common Stock | D | 5.031.214 | ||||||||
| 2017-02-24 | 3 | Healthcare Partners IX, LLC | LPTX | Common Stock | D | 5.031.214 | ||||||||
| 2017-01-25 | 2017-01-23 | 4 | LI WILLIAM | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 3 | ONSI DOUGLAS E See Footnotes | LPTX | Common Stock | I | 5.718.992 | ||||||||
| 2017-01-23 | 3 | ONSI DOUGLAS E See Footnotes | LPTX | Common Stock | I | 5.718.992 | ||||||||
| 2017-01-23 | 3 | LAWLOR AUGUSTINE See Footnotes | LPTX | Common Stock | I | 10.955.804 | ||||||||
| 2017-01-23 | 3 | LAWLOR AUGUSTINE See Footnotes | LPTX | Common Stock | I | 10.955.804 | ||||||||
| 2017-01-23 | 3 | Mashiach Nissim | LPTX | Common Stock | D | 0 | ||||||||
| 2017-01-23 | 3 | CAVANAUGH JAMES H | LPTX | Common Stock | I | 5.236.812 | ||||||||
| 2017-01-23 | 3 | CAVANAUGH JAMES H | LPTX | Common Stock | I | 5.236.812 | ||||||||
| 2017-01-23 | 3 | LITTLECHILD JOHN W | LPTX | Common Stock | I | 5.236.812 | ||||||||
| 2017-01-23 | 3 | LITTLECHILD JOHN W | LPTX | Common Stock | I | 5.236.812 | ||||||||
| 2017-01-23 | 3 | WERNER HAROLD R | LPTX | Common Stock | D | 5.236.812 | ||||||||
| 2017-01-23 | 3 | WERNER HAROLD R | LPTX | Common Stock | D | 5.236.812 | ||||||||
| 2017-01-23 | 3 | WERNER HAROLD R | LPTX | Common Stock | D | 5.236.812 | ||||||||
| 2017-01-23 | 3 | WERNER HAROLD R | LPTX | Common Stock | D | 5.236.812 | ||||||||
| 2017-01-23 | 3 | WERNER HAROLD R | LPTX | Common Stock | D | 5.236.812 | ||||||||
| 2017-01-23 | 3 | Mirabelli Christopher See Footnotes | LPTX | Common Stock | I | 10.955.804 | ||||||||
| 2017-01-23 | 3 | Mirabelli Christopher See Footnotes | LPTX | Common Stock | I | 10.955.804 | ||||||||
| 2017-01-23 | 2017-01-23 | 4 | Mirabelli Christopher | LPTX | Stock Option (Right to Buy) | D | 9,90 | 330.303 | 330.303 | |||||
| 2017-01-23 | 2017-01-23 | 4 | ONSI DOUGLAS E | LPTX | Stock Option (Right to Buy) | D | 9,90 | 330.303 | 330.303 | |||||
| 2017-01-23 | 2017-01-23 | 4 | LAWLOR AUGUSTINE | LPTX | Stock Option (Right to Buy) | D | 9,90 | 330.303 | 330.303 | |||||
| 2017-01-23 | 2017-01-23 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | LITTLECHILD JOHN W | LPTX | Stock Option (Right to Buy) | D | 9,90 | 11.000 | 11.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | LOSCALZO JOSEPH | LPTX | Stock Option (Right to Buy) | D | 9,90 | 11.000 | 11.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | Mashiach Nissim | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | CAVANAUGH JAMES H | LPTX | Stock Option (Right to Buy) | D | 9,90 | 11.000 | 11.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 9,90 | 15.000 | 15.000 | |||||
| 2017-01-23 | 2017-01-23 | 4 | Dietz Thomas John | LPTX | Stock Option (Right to Buy) | D | 9,90 | 11.000 | 11.000 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
